04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Pavillon 52 > Forschungsgruppe Experimentelle Hämostase

Up a level
Export as [feed] RSS
Group by: Date | UniBE Contributor | Item Type | Refereed | No Grouping
Number of items at this level: 41.

Journal Article

Li, Bojun; Bechtler, Clément; Jenny, Lorenz; Ricklin, Daniel; Schroeder, Verena (2022). Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners. Research and practice in thrombosis and haemostasis, 6(5), e12766. Wiley 10.1002/rth2.12766

Mutch, Nicola J; Walters, Sam; Gardiner, Elizabeth E; McCarty, Owen J T; De Meyer, Simon F; Schroeder, Verena; Meijers, Joost C M (2022). Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH. Journal of thrombosis and haemostasis, 20(6), pp. 1496-1506. Wiley-Blackwell 10.1111/jth.15718

Golomingi, Murielle; Kohler, Jessie; Jenny, Lorenz; Hardy, Elaissa T; Dobó, József; Gál, Péter; Pál, Gábor; Kiss, Bence; Lam, Wilbur A; Schroeder, Verena (2022). Complement lectin pathway components MBL and MASP-1 promote haemostasis upon vessel injury in a microvascular bleeding model. Frontiers in immunology, 13, p. 948190. Frontiers Research Foundation 10.3389/fimmu.2022.948190

Sánchez van Kammen, Mayte; Heldner, Mirjam R.; Brodard, Justine; Scutelnic, Adrian; Silvis, Suzanne; Schroeder, Verena; Kremer Hovinga, Johanna A.; Middeldorp, Saskia; Levi, Marcel; Hiltunen, Sini; Lindgren, Erik; Mansour, Maryam; Arauz, Antonio; Barboza, Miguel A.; Zuurbier, Susanna M.; Aguiar de Sousa, Diana; Ferro, Jose M.; Fischer, Urs; Field, Thalia S.; Jood, Katarina; ... (2021). Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA : the journal of the American Medical Association, 326(4), pp. 332-338. American Medical Association 10.1001/jama.2021.9889

Schroeder, Verena (2020). Laboratory Assessment of Coagulation Factor XIII. Hämostaseologie, 40(4), pp. 467-471. Thieme 10.1055/a-1181-0327

Heldner, Mirjam R.; Zuurbier, Susanna M.; Li, Bojun; von Martial, Rascha; Meijers, Joost C. M.; Zimmermann, Rebekka; Volbers, Bastian; Jung, Simon; El-Koussy, Marwan; Fischer, Urs; Kohler, Hans P.; Schroeder, Verena; Coutinho, Jonathan M.; Arnold, Marcel (2020). Prediction of Cerebral Venous Thrombosis with a new clinical score and D-dimer levels. Neurology, 95(7), e898-e909. American Academy of Neurology 10.1212/WNL.0000000000009998

Li, Bojun; Kohler, Hans P.; Schroeder, Verena (2020). Identification of amino acid residues that are crucial for FXIII-A intersubunit interactions and stability. Blood, 135(2), pp. 145-152. American Society of Hematology 10.1182/blood.2019002127

Jenny, Lorenz; Melmer, Andreas; Laimer, Markus; Hardy, Elaissa T; Lam, Wilbur A; Schroeder, Verena (2020). Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study. Diabetes & vascular disease research, 17(1), p. 1479164120903044. Sage 10.1177/1479164120903044

Orosz, Zsuzsanna Z; Bárdos, Helga; Shemirani, Amir H; Beke Debreceni, Ildikó; Lassila, Riitta; Riikonen, Antti S; Kremer Hovinga, Johanna A.; Seiler, Theo G.; van Dorland, Hendrika A.; Schroeder, Verena; Boda, Zoltán; Nemes, László; Früh Epstein, Beatrice; Nagy, Bence; Facskó, Andrea; Kappelmayer, János; Muszbek, László (2019). Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes. International journal of molecular sciences, 20(23) Molecular Diversity Preservation International MDPI 10.3390/ijms20235963

Jenny, Lorenz; Noser, Danilo; Larsen, Julie Brogaard; Dobó, József; Gál, Péter; Pál, Gábor; Schroeder, Verena (2019). MASP-1 of the complement system alters fibrinolytic behaviour of blood clots. Molecular immunology, 114, pp. 1-9. Elsevier 10.1016/j.molimm.2019.07.005

Ajjan, Ramzi A; Schroeder, Verena (2019). Role of complement in diabetes. Molecular immunology, 114, pp. 270-277. Elsevier 10.1016/j.molimm.2019.07.031

Li, Bojun; Heldner, Mirjam R.; Arnold, Marcel; Coutinho, Jonathan M; Zuurbier, Susanna M; Meijers, Joost C M; Kohler, Hans P; Schroeder, Verena (2019). Coagulation Factor XIII in Cerebral Venous Thrombosis. TH open, 3(3), e227-e229. Thieme 10.1055/s-0039-1693487

Engelberger, Rolf P; Schroeder, Verena; Nagler, Michael; Prince, Raja; Périard, Daniel; Hayoz, Daniel; Kucher, Nils (2019). Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein Thrombosis. Thrombosis and haemostasis, 119(7), pp. 1094-1101. Thieme 10.1055/s-0039-1688973

Li, Bojun; Billur, Ramya; Maurer, Muriel C; Kohler, Hans-Peter; Raddatz Müller, Pascale; Alberio, Lorenzo; Schroeder, Verena (2018). Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation. Thrombosis and haemostasis, 118(12), pp. 2037-2045. Thieme 10.1055/s-0038-1675600

Li, Bojun; Borhany, Munira; Abid, Madiha; Kohler, Hans-Peter; Schroeder, Verena (2018). Identification of a novel nonsense mutation leading to congenital factor XIII deficiency. Thrombosis research, 165, pp. 83-85. Elsevier 10.1016/j.thromres.2018.03.019

Jenny, Lorenz; Dobó, József; Gál, Péter; Pál, Gábor; Lam, Wilbur A; Schroeder, Verena (2018). MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. PLoS ONE, 13(1), e0191292. Public Library of Science 10.1371/journal.pone.0191292

Kool, Remi O; Kohler, Hans P.; Coutinho, Jonathan M; Levi, Marcel; Coppens, Michiel; Meijers, Joost C M; Schroeder, Verena (2017). Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis. Thrombosis research, 159, pp. 96-99. Elsevier 10.1016/j.thromres.2017.10.009

Schroeder, Verena; Kohler, Hans P (2016). Factor XIII: Structure and Function. Seminars in thrombosis and hemostasis, 42(4), pp. 422-428. Thieme Medical Publishers 10.1055/s-0036-1571341

Handrková, Helena; Schroeder, Verena; Kohler, H P (2015). The activation peptide of coagulation factor XIII is vital for its expression and stability. Journal of thrombosis and haemostasis, 13(8), pp. 1449-1458. Wiley-Blackwell 10.1111/jth.13035

Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 of the complement system promotes clotting via prothrombin activation. Molecular immunology, 65(2), pp. 398-405. Elsevier 10.1016/j.molimm.2015.02.014

Handrková, Helena; Borhany, M; Schroeder, Verena; Fatima, N; Hussain, A; Shamsi, T; Kohler, H P (2015). Identification of two novel missense mutations causing severe factor XIII deficiency. Haemophilia, 21(3), e253-e256. Blackwell Science 10.1111/hae.12663

Jenny, Lorenz; Ajjan, Ramzi; King, Rhodri; Thiel, Steffen; Schroeder, Verena (2015). Plasma Levels of MASP-1 and MASP-2 are Elevated in Type 1 Diabetes and Correlate with Glycaemic Control. Clinical and experimental immunology, 180(2), pp. 227-232. Blackwell Scientific Publications 10.1111/cei.12574

Schroeder, Verena; Handrková, Helena; Dodt, Johannes; Kohler, Hans-Peter (2015). Free factor XIII activation peptide affects factor XIII function. British journal of haematology, 168(5), pp. 757-759. Wiley-Blackwell 10.1111/bjh.13144

Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1. PLoS ONE, 10(12), e0144633. Public Library of Science 10.1371/journal.pone.0144633

Schroeder, Verena; Carter, A M; Dunne, J; Mansfield, M W; Grant, P J (2010). Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes. Journal of thrombosis and haemostasis, 8(9), pp. 2080-2082. Wiley-Blackwell 10.1111/j.1538-7836.2010.03966.x

Polkinghorne, Victoria R; Standeven, Kristina F; Schroeder, Verena; Carter, Angela M (2009). Role of proteomic technologies in understanding risk of arterial thrombosis. Expert review of proteomics, 6(5), pp. 539-550. Taylor & Francis 10.1586/epr.09.75

Castaman, G; Giacomelli, S H; Ivaskevicius, V; Schroeder, Verena; Kohler, Hans-Peter; Dragani, A; Biasioli, C; Oldenburg, J; Madeo, D; Rodeghiero, F (2008). Molecular characterization of five Italian families with inherited severe factor XIII deficiency. Haemophilia, 14(1), pp. 96-102. Wiley 10.1111/j.1365-2516.2007.01603.x

Schroeder, Verena; Durrer, Dominik; Meili, Esther; Schubiger, Gregor; Kohler, Hans Peter (2007). Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss medical weekly, 137(19-20), pp. 272-278. EMH Media 10.4414/smw.2007.11756

Schmid, Jean-Paul; Schroeder, Verena (2005). Nicorandil – Review of Pharmacological Properties and Clinical Applications. Heart drug, 5(4), pp. 220-229. Karger 10.1159/000089603

Kucher, Nils; Schroeder, Verena; Kohler, Hans P (2003). Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Thrombosis and haemostasis, 90(3), pp. 434-438. Schattauer 10.1160/TH03-07-0031

Chatterjee, T; Schroeder, Verena; Windecker, S; Meier, B; Kohler, H P (2003). Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease. Journal of thrombosis and haemostasis, 1(4), pp. 861-863. Blackwell 10.1046/j.1538-7836.2003.t01-8-00115.x

Schroeder, Verena; Kucher, N; Kohler, H P (2003). Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism. Journal of thrombosis and haemostasis, 1(3), pp. 492-493. Blackwell 10.1046/j.1538-7836.2003.00112.x

Schroeder, Verena; Kohler, Hans P (2003). Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype. Blood, 101(1), pp. 371-372. American Society of Hematology 10.1182/blood-2002-08-2427

Schroeder, Verena; Chatterjee, Tushar; Mehta, Haresh; Windecker, Stephan; Pham, Trinh; Devantay, Nicolas; Meier, Bernhard; Kohler, Hans P (2002). Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thrombosis and haemostasis, 88(6), pp. 1020-1025. Schattauer

Ferrari, Paolo; Schroeder, Verena; Anderson, Suzanne; Kocovic, Leonardo; Vogt, Bruno; Schiesser, Daniela; Marti, Hans-Peter; Ganz, Reinhold; Frey, Felix J; Kohler, Hans P (2002). Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation, 74(8), pp. 1147-1152. Lippincott Williams & Wilkins 10.1097/01.TP.0000035848.73883.1B

Wilmer, M.; Schroeder, Verena; Kohler, H. P. (2002). Methoden zur Bestimmung des Faktors XIII/XIIIa. Hämostaseologie, 22(01), pp. 18-28. Schattauer 10.1055/s-0037-1622004

Kohler, H.P.; Schroeder, Verena (2002). Die Rolle von Faktor XIII bei kardio- und zerebrovaskulären Erkrankungen. Hämostaseologie, 22(01), pp. 39-44. Schattauer 10.1055/s-0037-1622007

Schroeder, Verena; Chatterjee, T; Kohler, H P (2001). Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thrombosis research, 104(6), pp. 467-474. Elsevier 10.1016/s0049-3848(01)00395-4

Schroeder, Verena; Kohler, H P (2000). Effect of factor XIII Val34Leu on alpha2-antiplasmin incorporation into fibrin. Thrombosis and haemostasis, 84(6), pp. 1128-1130. Schattauer

Book Section

Schroeder, Verena; Kohler, H.-P. (2010). Faktor XIII. In: Pötsch, Bernd; Madlener, Katharina (eds.) Hämostaseologie. Grundlagen, Diagnostik und Therapie (pp. 219-225). Springer


Schroeder, Verena (2003). Role of blood coagulation factor XII in vascular diseases and characterisation of genetic variants (Unpublished). (Dissertation, University of Basel, Faculty of Science)

This list was generated on Tue Nov 29 04:13:51 2022 CET.
Provide Feedback